These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 15651059

  • 1. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Shenkier TN, Voss N, Chhanabhai M, Fairey R, Gascoyne RD, Hoskins P, Klasa R, Morris J, O'Reilly SE, Pickles T, Sehn L, Connors JM.
    Cancer; 2005 Mar 01; 103(5):1008-17. PubMed ID: 15651059
    [Abstract] [Full Text] [Related]

  • 2. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr 01; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

  • 3. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Homma J, Sano M, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Kakuma T, Tanaka R.
    Jpn J Clin Oncol; 2008 May 01; 38(5):373-80. PubMed ID: 18413337
    [Abstract] [Full Text] [Related]

  • 4. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM.
    J Clin Oncol; 2005 Jul 01; 23(19):4430-8. PubMed ID: 15883411
    [Abstract] [Full Text] [Related]

  • 5. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, Takahashi H, Onda K, Takahashi H, Tanaka R.
    Ann Hematol; 2005 Jul 01; 84(7):447-55. PubMed ID: 15747120
    [Abstract] [Full Text] [Related]

  • 6. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
    Laack NN, Ballman KV, Brown PB, O'Neill BP, North Central Cancer Treatment Group.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1429-39. PubMed ID: 16863926
    [Abstract] [Full Text] [Related]

  • 7. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Kiewe P, Fischer L, Martus P, Thiel E, Korfel A.
    Cancer; 2008 Apr 15; 112(8):1812-20. PubMed ID: 18318432
    [Abstract] [Full Text] [Related]

  • 8. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 9. New treatment options have changed the survival of patients with follicular lymphoma.
    Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP.
    J Clin Oncol; 2005 Nov 20; 23(33):8447-52. PubMed ID: 16230674
    [Abstract] [Full Text] [Related]

  • 10. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A.
    Cancer; 2005 Mar 01; 103(5):970-7. PubMed ID: 15666323
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW, Kim DY, Yun T, Kim DW, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK.
    Cancer; 2003 Dec 15; 98(12):2651-6. PubMed ID: 14669285
    [Abstract] [Full Text] [Related]

  • 12. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 15; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 13. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE.
    Cancer; 2008 Sep 01; 113(5):1025-31. PubMed ID: 18618509
    [Abstract] [Full Text] [Related]

  • 14. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.
    J Clin Oncol; 2006 Aug 20; 24(24):3865-70. PubMed ID: 16864853
    [Abstract] [Full Text] [Related]

  • 15. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
    Singhal D, Witham TF, Germanwala A, Flickinger JC, Schiff D, Kondziolka D.
    Can J Neurol Sci; 2002 May 20; 29(2):147-53. PubMed ID: 12035835
    [Abstract] [Full Text] [Related]

  • 16. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G, Dreyling M, Hoster E, Wörmann B, Dührsen U, Metzner B, Eimermacher H, Neubauer A, Wandt H, Steinhauer H, Martin S, Heidemann E, Aldaoud A, Parwaresch R, Hasford J, Unterhalt M, Hiddemann W.
    J Clin Oncol; 2005 Mar 20; 23(9):1984-92. PubMed ID: 15668467
    [Abstract] [Full Text] [Related]

  • 17. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
    Mead GM, Bleehen NM, Gregor A, Bullimore J, Shirley D, Rampling RP, Trevor J, Glaser MG, Lantos P, Ironside JW, Moss TH, Brada M, Whaley JB, Stenning SP.
    Cancer; 2000 Sep 15; 89(6):1359-70. PubMed ID: 11002232
    [Abstract] [Full Text] [Related]

  • 18. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

  • 19. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
    Micallef IN, Kahl BS, Maurer MJ, Dogan A, Ansell SM, Colgan JP, Geyer S, Inwards DJ, White WL, Habermann TM.
    Cancer; 2006 Dec 15; 107(12):2826-32. PubMed ID: 17099879
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
    Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE.
    Cancer; 2010 Oct 01; 116(19):4605-12. PubMed ID: 20572045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.